Literature DB >> 20451829

The feasibility of facial-submental artery island myocutaneous flaps for reconstructing defects of the oral floor following cancer ablation.

Yun-hua You1, Wei-liang Chen, Yue-ping Wang, Jun Liang.   

Abstract

OBJECTIVE: The aim of the present study was to evaluate the feasibility of clinically applying facial-submental artery island flaps on primary reconstruction of oral floor defects following cancer ablation. STUDY
DESIGN: Facial-submental artery island flaps were used to repair defects in the floor of the mouth after cancer ablation in 7 patients (5 men and 2 women; age range, 43-64 years; average age, 51.2 years). Two patients were classified as T(1)N(0)M(0), and 5 were classified as T(2)N(0)M(0). The skin paddles ranged in size from 4.0 x 10.0 cm to 5.0 x 11.0 cm.
RESULTS: Six flaps survived completely, and the success rate was therefore 86% (6 of 7). The remaining flap showed minimal partial necrosis. All of the patients were followed for 6 to 25 months. The speech and swallowing functions following surgery were well recovered, and the patients were satisfied with their facial appearance.
CONCLUSION: Facial-submental artery island myocutaneous flaps are suitable for repairing small and medium-sized defects of the oral floor. Copyright 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20451829     DOI: 10.1016/j.tripleo.2010.02.004

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  3 in total

1.  Submental Perforator Flap for Soft-Tissue Reconstruction in Bisphosphonate-Related Osteonecrosis of the Jaws.

Authors:  Jose-Antonio García-de Marcos; Juan Rey-Biel
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2016-11-01

2.  Oral reconstruction with submental flap.

Authors:  Amin Rahpeyma; Saeedeh Khajehahmadi
Journal:  Ann Maxillofac Surg       Date:  2013-07

3.  Clinical reliability of radial forearm free flap in repair of buccal defects.

Authors:  Qi-Gen Fang; Zhen-Ning Li; Xu Zhang; Fa-Yu Liu; Zhong-Fei Xu; Chang-Fu Sun
Journal:  World J Surg Oncol       Date:  2013-01-30       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.